Fei Xiao

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

Joachim Lupberger, Mirjam B. Zeisel, Fei Xiao et al. · Nature Medicine · 2011 · 684 citations · Full text

Viral Hepatitis, Host Factors, Immunology +6

Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19

Fei Xiao, Jing Sun, Yonghao Xu et al. · Emerging infectious diseases · 2020 · 551 citations · Full text

Respiratory Diseases, Medicine, Covid-19 Pandemic +12

Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China

Fang Lei, Ye‐Mao Liu, Feng Zhou et al. · Hepatology · 2020 · 445 citations · Full text

The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι

Yiwen Zhang, Yingshi Chen, Yuzhuang Li et al. · Proceedings of the National Academy of Sciences · 2021 · 436 citations · Full text

Viral Pathogenesis, Immunology, Immunologic Mechanism +18

Psychological status and behavior changes of the public during the COVID-19 epidemic in China

Xi Liu, Wen-Tao Luo, Ying Li et al. · Infectious Diseases of Poverty · 2020 · 385 citations · Full text